Minerva Neurosciences, Inc.
NERV
$2.39
-$0.045-1.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.23M | 6.25M | 1.44M | -3.31M | -33.65M |
| Total Depreciation and Amortization | 5.60K | 5.60K | 5.60K | 5.60K | 5.60K |
| Total Amortization of Deferred Charges | 4.30K | 10.70K | 17.10K | 23.50K | 25.60K |
| Total Other Non-Cash Items | -25.43M | -23.08M | -20.69M | -18.14M | 10.59M |
| Change in Net Operating Assets | -1.45M | -715.90K | -320.60K | 1.05M | 2.20M |
| Cash from Operations | -15.63M | -17.53M | -19.55M | -20.38M | -20.83M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -86.70K |
| Cash from Financing | -- | -- | -- | 0.00 | -86.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.63M | -17.53M | -19.55M | -20.38M | -20.92M |